ORLANDO (EGMN) – An investigational inhaled insulin plus injected glargine produced equivalent reductions in hemoglobin A1c compared with injected biphasic insulin, but with less hypoglycemia and weight gain, in a 1-year, randomized, open-label trial of 448 adults with type 2 diabetes who were in poor control despite insulin treatment.
